ResMed | Értékesítés



Sales változás Dátum
Ansell USD 834.4M 49.5M 2024-06
AtriCure USD 124.28M 8.37M 2024-12
Baxter International USD 2.75B 54M 2024-12
Cochlear AUD 1.14B 38.6M 2024-06
Cooper Companies USD 964.7M 53.7M 2025-01
CSL USD 6.75B 1.31B 2024-06
Dexcom USD 1.11B 119.3M 2024-12
Edwards Lifesciences USD 1.39B 31.4M 2024-12
Fisher Paykel Healthcare NZD 951.2M 12.1M 2024-09
Globus Medical USD 657.29M 31.59M 2024-12
Haemonetics USD 348.54M 3.03M 2024-12
Hologic USD 1.02B 33.9M 2024-12
Idexx Laboratories USD 954.29M 21.26M 2024-12
Insulet USD 597.5M 53.6M 2024-12
Integra LifeSciences USD 442.65M 61.81M 2024-12
Intuitive Surgical USD 2.41B 370M 2024-12
Masimo USD 600.7M 96.1M 2024-12
Medtronic USD 8.29B 111M 2025-01
Philips EUR 5.04B 644M 2024-12
Ramsay Health Care AUD 8.59B 12M 2024-12
ResMed USD 1.28B 57.58M 2024-12
Sigma Healthcare AUD 1.88B 198.62M 2024-07
Sonic Healthcare AUD 4.67B 9M 2024-12
Steris USD 1.37B 41.66M 2024-12
Teleflex USD 795.41M 31.03M 2024-12
Thermo Fisher Scientific USD 11.4B 797M 2024-12



ResMed Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.